In AD patients, increased TREM2 levels have been reported in the CSF [22, 24, 41, 42, 55], together with positive immunoreactivity in the microglia associated with β-amyloid plaques and in neuritic pathology-enriched areas [41]. The gene discussed is TREM2; the disease is Alzheimer disease.